复方丹参滴丸联合氨氯地平治疗原发性高血压的疗效及对血清Hcy、β2-微球蛋白、VEGF水平的影响

摘要/Abstract

摘要： 目的研究复方丹参滴丸以及氨氯地平联用对原发性高血压的疗效及对血清同型半胱氨酸（Hcy）、β2-微球蛋白、血管内皮细胞生长因子（VEGF）水平的影响。方法选取2020年1月—2022年12月格尔木市人民医院收治的80例原发性高血压患者作为研究对象,依据随机数表法将其分为观察组和对照组,每组40例。对照组采用氨氯地平治疗,观察组在对照组治疗基础上联用复方丹参滴丸。评估并比较两组患者的眩晕昏蒙、项背强硬、肢体麻木、胸闷胸痛症状,且检测并比较血清Hcy、β2-微球蛋白和VEGF水平。结果观察组的有效率明显高于对照组,差异有统计学意义（P<0.05）。治疗前,两组患者的眩晕昏蒙、项背强硬、肢体麻木和胸闷胸痛症状积分比较,差异无统计学意义（P>0.05）;治疗后,两组患者的眩晕昏蒙、项背强硬、肢体麻木和胸闷胸痛症状积分均明显降低（P<0.05）,且观察组患者的眩晕昏蒙、项背强硬、肢体麻木和胸闷胸痛症状积分更低,差异有统计学意义（P<0.05）。治疗前,两组患者的血清Hcy、β2-微球蛋白和VEGF水平比较,差异无统计学意义（P>0.05）;治疗后,两组患者的血清Hcy、β2-微球蛋白和VEGF水平均明显降低（P<0.05）,且观察组患者的血清Hcy、β2-微球蛋白和VEGF水平明显低于对照组,差异有统计学意义（P<0.05）。结论复方丹参滴丸以及氨氯地平联用对原发性高血压有显著的疗效,能明显降低Hcy、β2-微球蛋白和VEGF水平。

关键词: 复方丹参滴丸, 氨氯地平, 原发性高血压, 同型半胱氨酸, β2-微球蛋白, 血管内皮细胞生长因子

Abstract: Objective To study the effect of compound salvia miltiorrhiza dropping pills combined with amlodipine in the treatment of essential hypertension and its effect on serum Hcy, β2-microglobulin and VEGF levels. Methods Selected 80 essential hypertension patients admitted to Golmud People's Hospital from January 2020 to December 2022 were selected, and the random number table was divided into observation group and control group, with 40 patients in each group. The control group used amlodipine, and the observation group used compound Danshen dropping based on the control group. Evaluate the symptoms of dizziness, stiff neck and back, numbness in limbs, and chest tightness and pain in both groups, and irritability symptoms of both groups, and test for serum Hcy β 2-Microglobulin and VEGF levels. Results The effective rate of the observation group was significantly higher than control group (P<0.05). Before treatment, there was no significant difference in the symptom scores of dizziness, stiff neck and back, numbness in limbs, and chest tightness and chest pain between the two groups (P>0.05). After treatment, the symptom scores of dizziness, stiff neck and back, numbness in limbs, and chest tightness and chest pain in both groups were significantly reduced (P<0.05), and the symptom scores of dizziness, stiff neck and back, numbness in limbs, and chest tightness and chest pain in the observation group were lower (P<0.05). Before treatment, there was no significant difference in the levels of serum Hcy, β2-microglobulin and VEGF (P>0.05). After treatment, the levels of serum Hcy, β2-microglobulin and VEGF were significantly reduced (P<0.05), and the levels of serum Hcy, β2-microglobulin and VEGF were significantly lower than those of the control group (P<0.05). Conclusion Compound Danshen dripping pills combined with amlodipine have significant effect on primary hypertension, and can significantly reduce the levels of serum Hcy, β2-microglobulin and VEGF levels.

Key words: Compound Danshen Dropping Pills, Amlodipine, primary hypertension, homocysteine, β2-Microglobulin, vascular endothelial cell growth factor

中图分类号:

R544.1

尹春财. 复方丹参滴丸联合氨氯地平治疗原发性高血压的疗效及对血清Hcy、β2-微球蛋白、VEGF水平的影响[J]. 中华养生保健, 2024, 42(6): 23-26.

YIN Chun-cai. The Curative Effect of Compound Salvia Miltiorrhiza Dropping Pills Combined with Amlodipine in the Treatment of PrimaryHypertension and its Effect on Serum Hcy, β2-microglobulin and VEGF levels[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(6): 23-26.

参考文献

[1] 杨尚磊,黄丽娟.氨氯地平阿托伐他汀钙片联合血府逐瘀软胶囊治疗原发性高血压合并颈动脉粥样硬化患者的疗效观察[J].世界中西医结合杂志,2021,16(1):108-112,118.
[2] 杨亚梅,赵卫国,王宏业,等.调脂清脑汤结合苯磺酸氨氯地平片治疗原发性高血压病的临床疗效及对血液流变学的影响[J].中华中医药学刊,2022,40(2):223-226.
[3] 刘永成,田颖,郭栋,等.复方丹参滴丸治疗原发性高血压的系统评价和Meta分析[J].中草药,2022,53(10):3111-3124.
[4] 中国高血压防治指南修订委员会.中国高血压防治指南(2010修订版)[J].中华高血压杂志,2011,19( 18):701-742.
[5] 中华中医药学会.高血压中医诊疗指南[J].中国中医药现代远程教育,2011,9(23):108-109.
[6] 周宗慧,王泓午,朱青青,等.半夏白术天麻汤联合温胆汤治疗原发性高血压有效性及安全性的Meta分析[J].中西医结合心脑血管病杂志,2022,20(20):3659-3665.
[7] 曾婉琪,罗艳,刘丹,等.原发性高血压患者血清低密度脂蛋白胆固醇及脂蛋白a与血压变异性的相关性[J].心肺血管病杂志,2022,41(7):768-772.
[8] 闫春秀,吕聪敏,李小妞,等.原发性高血压患者血压变异性与炎症标志物及颈动脉粥样硬化程度的相关性分析[J].中国循证心血管医学杂志,2022,14(1):102-104,107.
[9] 康彦同,赵丽贞.心脉通胶囊联合苯磺酸左旋氨氯地平片对原发性高血压病人血清炎性因子及血管内皮功能的影响[J].中西医结合心脑血管病杂志,2021,19(7):1137-1140.
[10] 娄满,王宏业,高春燕,等.左旋氨氯地平夜间给药对非杓型高血压患者动态动脉硬化指数及尿微量白蛋白的影响[J].中国循证心血管医学杂志,2021,13(6):705-708.
[11] 曲曼古丽·阿布力孜,居来提·艾买提,阿布都沙拉木·阿布都热衣木.夏枯草汤联合氨氯地平治疗老年高血压病的效果及对CysC,ET-1水平的影响[J].西部中医药,2021,34(9):114-117.
[12] 刘琳琳,刘松雅.氨氯地平联合贝那普利对急性脑梗死合并高血压患者血压控制效果及外周血同型半胱氨酸水平的影响[J].中国药物与临床,2021,21(24):4015-4017.
[13] 马有刚,康峰光,徐如林,等.复方丹参滴丸减少心肌微血管内皮-间质转化保护缺血-再灌注大鼠的心功能[J].中山大学学报(医学科学版),2021,42(3):355-363.
[14] 马利菊,杜平,孙许锋,等.复方丹参滴丸联合阿托伐他汀对急性脑梗死患者颈动脉粥样硬化斑块稳定性超声参数及血清LDL-C和D-D的影响[J].现代中西医结合杂志,2022,31(15):2104-2107,2145.
[15] 李幸幸,刘俊,徐忠诚,等.复方丹参滴丸通过调控IRE1-TRAF2-ASK1-JNK通路降低内质网应激和自噬保护血管平滑肌细胞[J].中国药理学通报,2022,38(5):776-783.
[16] 周欢,余黄鹏.复方丹参滴丸辅助西医降压药治疗对原发性高血压患者疗效和血脂的影响[J].中国当代医药,2021,28(19):155-157,161.
[17] 陈哲,彭莹莹,杨丰文,等.复方丹参滴丸联合常规降压治疗高血压病左心室肥厚临床疗效和安全性的Meta分析[J].中国中药杂志,2021,46(10):2578-2587.
[18] 刘宝. 原发性高血压病人血清25(OH)D与血压波动性和血管内皮功能的关系探讨[J].中西医结合心脑血管病杂志,2022,20(16):3004-3007.
[19] 梁燕飞,朱英标,李俊慧.清肝降压胶囊治疗原发性高血压的有效性及对患者血清同型半胱氨酸和血管内皮生长因子水平的影响[J].中国医药,2021,16(6):837-840.
[20] 梁蕴瑜,谢平畅,钟言,等.外周血HCY、PLR及hs-CRP预测原发性高血压患者颈动脉粥样硬化的诊断效能[J].现代生物医学进展,2021,21(16):3110-3114.